Remove company outcomes
article thumbnail

Gilead's Trodelvy fails to extend survival in lung cancer study, prompting selloff

Fierce Pharma

Even as Gilead looks to become an oncology powerhouse in the coming years, the company on Monday recorded a major setback for its antibody-drug conjugate (ADC) Trodelvy. | The trial outcome marks a setback in Gilead's ambition to grow its presence in the oncology sector.

Patients 280
article thumbnail

Addressing the evolving needs of pharma for CDx development

Fierce Pharma

Agilent Technologies discusses the importance of working with pharmaceutical companies to drive medical innovation and improve patient outcomes, helping to speed up the process of bringing the right treatments to the right patients at the right time. Partnerships in healthcare have never been more important.

Pharma 180
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Breaking Down Barriers to Obesity Care

MedCity News

How targeted outreach and heightened engagement can help companies achieve better outcomes

Patients 117
article thumbnail

An Evolving ‘Opinion’ Landscape: New Paths—and Synergies—for Pharma KOLs & DOLs

PharmExec

Industry experts discuss the relationship between digital and traditional (key) opinion leaders and how companies are adjusting their strategies to harness the unique brand engagement benefits each role can provide in driving better patient outcomes.

Pharma 119
article thumbnail

Two Chairs Unveils Group Therapy, Care Navigation Offerings

MedCity News

Mental health company Two Chairs launched two new solutions Tuesday: group therapy and care navigation. The offerings will help improve access to mental health care and lead to better clinical outcomes, said Alex Katz, CEO and founder of the company

Leads 103
article thumbnail

Payers Need Clear Outcomes Data to Reimburse Digital Health, Experts Argue

MedCity News

It’s clear that services like telehealth and remote patient monitoring have potential to provide value within the healthcare industry, but hospitals and digital health companies need to show payers clearer evidence of the outcomes these care modalities can produce in order to earn reimbursement, panelists argued during MedCity’s INVEST conference. (..)

article thumbnail

PhRMA lies to protect pharma profits

World of DTC Marketing

pharmaceutical companies booked tens of billions of dollars in revenue: Johnson & Johnson ($94 billion), Pfizer ($81 billion), AbbVie ($56 billion), Merck & Co. ($49 Drug companies tend to say they are unique in needing to spend a higher proportion of their capital on research than almost any other industry. It’s Amazon.

Pharma 255